ES2094171T3 - Composicion que contiene proteasa producida mediante vibrio, y procedimiento utilizado en el desbridamiento y curacion de heridas. - Google Patents

Composicion que contiene proteasa producida mediante vibrio, y procedimiento utilizado en el desbridamiento y curacion de heridas.

Info

Publication number
ES2094171T3
ES2094171T3 ES91112732T ES91112732T ES2094171T3 ES 2094171 T3 ES2094171 T3 ES 2094171T3 ES 91112732 T ES91112732 T ES 91112732T ES 91112732 T ES91112732 T ES 91112732T ES 2094171 T3 ES2094171 T3 ES 2094171T3
Authority
ES
Spain
Prior art keywords
protease
image
vibrio
debriding
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91112732T
Other languages
English (en)
Spanish (es)
Inventor
Donald Zane Fortney
Donald Richard Durham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WR Grace and Co Conn
WR Grace and Co
Original Assignee
WR Grace and Co Conn
WR Grace and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/567,884 external-priority patent/US5145681A/en
Application filed by WR Grace and Co Conn, WR Grace and Co filed Critical WR Grace and Co Conn
Application granted granted Critical
Publication of ES2094171T3 publication Critical patent/ES2094171T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/63—Vibrio
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/909—Vibrio

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
ES91112732T 1990-08-15 1991-07-29 Composicion que contiene proteasa producida mediante vibrio, y procedimiento utilizado en el desbridamiento y curacion de heridas. Expired - Lifetime ES2094171T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/567,884 US5145681A (en) 1990-08-15 1990-08-15 Compositions containing protease produced by vibrio and method of use in debridement and wound healing
US67061291A 1991-03-13 1991-03-13

Publications (1)

Publication Number Publication Date
ES2094171T3 true ES2094171T3 (es) 1997-01-16

Family

ID=27074608

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91112732T Expired - Lifetime ES2094171T3 (es) 1990-08-15 1991-07-29 Composicion que contiene proteasa producida mediante vibrio, y procedimiento utilizado en el desbridamiento y curacion de heridas.

Country Status (10)

Country Link
US (1) US5505943A (fr)
EP (1) EP0472011B1 (fr)
JP (1) JP3253108B2 (fr)
AT (1) ATE145139T1 (fr)
CA (1) CA2046802C (fr)
DE (1) DE69123099T2 (fr)
DK (1) DK0472011T3 (fr)
ES (1) ES2094171T3 (fr)
GR (1) GR3022412T3 (fr)
NZ (1) NZ238954A (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840836A (en) * 1989-02-17 1998-11-24 Bayer Corporation Pancreatic islet cell antigens obtained by molecular cloning
US6811989B1 (en) * 1989-02-17 2004-11-02 Bayer Corporation Pancreatic islet cell antigens obtained by molecular cloning
US5468505A (en) * 1992-02-28 1995-11-21 Board Of Regents, The University Of Texas System Local delivery of fibrinolysis enhancing agents
EP0661293A3 (fr) * 1993-12-29 1999-05-19 Sanwa Kagaku Kenkyusho Co., Ltd. Protéine à action stimulante sur la croissance des cellules et macrophage-chimiotactique, procédé de préparation et utilisation
GB9502120D0 (en) * 1995-02-03 1995-03-22 Chiroscience Ltd Purified enzyme and its preparation
US6017531A (en) * 1997-06-02 2000-01-25 W. R. Grace & Co. Hydrophilic composition containing protease produced by Vibrio
US7184963B1 (en) 1999-01-19 2007-02-27 Bristol-Myers Squibb Company Method for determining care and prevention pathways for clinical management of wounds
EP1169055A4 (fr) * 1999-01-19 2009-10-21 Bristol Myers Squibb Co Methode d'etablissement de protocoles de soin et de prevention permettant la surveillance clinique des plaies
AU2002257295B2 (en) * 2001-05-16 2008-06-12 Biomarin Pharmaceutical Inc. Destruction of prions using vibriolysin or variants thereof
US7223386B2 (en) * 2002-03-11 2007-05-29 Dow Corning Corporation Preparations for topical skin use and treatment
US20030180281A1 (en) * 2002-03-11 2003-09-25 Bott Richard R. Preparations for topical skin use and treatment
US20030198631A1 (en) * 2002-04-18 2003-10-23 Healthpoint, Ltd. Thermolysin enzymatic wound debrider
US7332179B2 (en) * 2003-12-12 2008-02-19 Kimberly-Clark Worldwide, Inc. Tissue products comprising a cleansing composition
US20050244480A1 (en) * 2004-04-30 2005-11-03 Kimberly-Clark Worldwide, Inc. Pre-wipes for improving anal cleansing
IL165334A0 (en) 2004-11-22 2006-01-15 Mediwound Ltd Debriding composition from bromelain and methods of producing same
US20060140899A1 (en) * 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. Skin cleansing system comprising an anti-adherent formulation and a cationic compound
US7642395B2 (en) * 2004-12-28 2010-01-05 Kimberly-Clark Worldwide, Inc. Composition and wipe for reducing viscosity of viscoelastic bodily fluids
JP2010536892A (ja) * 2007-08-31 2010-12-02 ディーエスエム アイピー アセッツ ビー．ブイ． 化粧的及び／又は皮膚科学的使用のための４−アミジノベンジルアミン
ATE521362T1 (de) * 2008-01-08 2011-09-15 Univ Tufts Wundheilungspeptide und verfahren zur verwendung davon
DE202017000266U1 (de) 2017-01-18 2017-03-29 Norbert Neubauer Debridement - Vorrichtung zur Wundheilung
DE202018002112U1 (de) 2018-04-26 2018-05-25 Norbert Neubauer Wund-Spül-Saugstab

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3409719A (en) * 1967-05-23 1968-11-05 Baxter Laboratories Inc Debridement agent
US3677900A (en) * 1970-05-04 1972-07-18 Univ Lehigh Method of producing collagenase with a species of vibrio
US4329430A (en) * 1979-06-04 1982-05-11 Klein Gerold K V Enzyme mixture
US4276281A (en) * 1980-09-04 1981-06-30 Crikelair George F Burn treatment
US4668228A (en) * 1985-03-12 1987-05-26 Johnson & Johnson Products, Inc. Debriding tape
US4966846A (en) * 1987-10-01 1990-10-30 W. R. Grace & Co.-Conn. Molecular cloning and expression of a vibrio proteolyticus neutral protease gene
US4865983A (en) * 1987-12-04 1989-09-12 W. R. Grace & Co.-Conn. Cleaning compositions containing protease produced by vibrio and method of use
US5145681A (en) * 1990-08-15 1992-09-08 W. R. Grace & Co.-Conn. Compositions containing protease produced by vibrio and method of use in debridement and wound healing
EP0498532A1 (fr) * 1991-01-10 1992-08-12 E.R. SQUIBB & SONS, INC. Poudre pour le débridement des tissus nécropés contenant une enzyme protéolytique

Also Published As

Publication number Publication date
NZ238954A (en) 1993-09-27
JP3253108B2 (ja) 2002-02-04
CA2046802A1 (fr) 1992-02-16
EP0472011B1 (fr) 1996-11-13
DK0472011T3 (da) 1996-12-02
CA2046802C (fr) 2007-05-22
DE69123099T2 (de) 1997-03-06
EP0472011A1 (fr) 1992-02-26
JPH05178761A (ja) 1993-07-20
US5505943A (en) 1996-04-09
DE69123099D1 (de) 1996-12-19
ATE145139T1 (de) 1996-11-15
GR3022412T3 (en) 1997-04-30

Similar Documents

Publication Publication Date Title
ES2094171T3 (es) Composicion que contiene proteasa producida mediante vibrio, y procedimiento utilizado en el desbridamiento y curacion de heridas.
EP0730465A4 (fr) Utilisation de l'angiotensine iii et de ses analogues pour la reparation tissulaire
US6932963B2 (en) Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
US10206982B2 (en) Wound debridement compositions containing seaprose and methods of wound treatment using same
ZA947337B (en) Use of angiotensin II analogs in tissue repair
MY112266A (en) Two part cleaning composition comprising at least one peroxide compound
FI955091A0 (fi) Parannetut farmaseuttisesti hyväksyttävät seokset, jotka sisältävät alkoholia ja hydrofobista lääkettä
EP0673234A4 (fr) Compositions protegeant et regenerant les tissus.
EP0824545A4 (fr) Compositions peptidiques presentant une activite du type facteur de croissance
EA200000045A1 (ru) Косметическая композиция, содержащая отбеливающее и отшелушивающее средства
RU94045952A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена
DE69030476D1 (de) Verwendung von Protease-Inhibitoren als antiexudative, antiphlogistische und antimikrobielle Mittel
AU7263591A (en) Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors
TW272974B (fr)
CO5080738A1 (es) Formulaciones para la proteccion de conjugados de peginter- feron alfa
US4276281A (en) Burn treatment
GB8925833D0 (en) Derivatives of aromatic benzoates as inhibitors of esterase-producing micro-organisms
WO1995015161A3 (fr) Medicament de traitement de l'insuffisance cardiaque
BR0107544A (pt) Composição de promoção de secreção de bile
EP0498532A1 (fr) Poudre pour le débridement des tissus nécropés contenant une enzyme protéolytique
BR9713955A (pt) Composição de alvejamento enzimática, e, processo para alvejamento de manchas presentes em tecidos.
CA1077837A (fr) Substance enzymatique, hydrolytique
CO4560484A1 (es) Composiciones polimericas antiestaticas de ionomeros y/o copolimero de olefina
DE69509657D1 (de) Verwendung von benzothiophenen zur herstellung eines medikaments zur verminderung der narbenbildung bei der wundheilung
WO2002049642A3 (fr) Utilisation d'acides 5-hydroxy et 5-acyloxy-2,3-dihydro-4,6,7-trimethyl-2-benzofuranacetiques et de leurs esters en tant qu'agents utiles pour cicatriser des lesions cutanees et stimulants de l'angiogenese

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 472011

Country of ref document: ES